Author: sugaradmin

Introduction and Objective: Clinical trials were not powered to examine if the cardiovascular (CV) benefits of empagliflozin (EMPA) in patients with type 2 diabetes (T2D) are consistent across demographic factors.Methods: Using Medicare data (2014-2020), we compared 1:1 propensity score-matched patients aged ≥65 years with T2D initiating EMPA vs DPP4i for MACE, hospitalization for heart failure […]

Introduction and Objective: SGLT2i have major cardiorenal benefits for people with type 2 diabetes. While some guidelines recommend temporarily withholding SGLT2i during hospitalization, limited evidence suggests many people may not restart SGLT2i following discharge. We examined if hospitalization was a risk factor for SGLT2i discontinuation, and if this differed to other diabetes therapy (DPP-4i) not […]

Introduction and Objective: Diabetes device use in T1D is associated with improved clinical outcomes. However, many people experience device-related skin reactions. Our aim was to assess psychosocial outcomes between YYA with T1D that experience device-related skin reactions and those that do not.Methods: YYA (2-25 years) with T1D that use diabetes devices completed an in-house developed […]

Introduction and Objective: Transgender, non-binary, and genderqueer people experience systematic barriers in receipt of medical care. Our objective was to understand patterns of diabetes treatment/outcomes for this population.Methods: Patients with an ICD code diagnosis of T2DM between 01/01/2021 and 01/13/2024 in nationwide Epic EHR data were included and A1c control, receipt of antidiabetic medication classes, […]

Introduction and Objective: The REGENT-1 trial evaluated the Re-Cellularization via Electroporation Therapy (ReCET™) System, which uses pulsed electric fields (PEF) to regenerate duodenal mucosa and submucosa. We examined the effect of ReCET™ across energy dose cohorts on CGM metrics.Methods: REGENT-1studied endoscopic PEF therapy at three doses in T2D adults on 1-4 non-insulin agents. Group 1) […]

Introduction and Objective: Few psychosocial interventions exist for families in the first year after a T1D diagnosis. Initial findings from the Triple T pilot, a telehealth intervention designed to support family coping during this first year are reported.Methods: Inclusion criteria: child with a new diagnosis of T1D and fluency in English. Families participated in 6 […]

Introduction and Objective: Habit theory describes context stability as important for the development of habit automaticity, but its role in insulin habit automaticity and adherence is unknown. The objective of the study was to examine the roles of context and context stability on insulin habit automaticity and adherence in adults with T1D.Methods: Adults with T1D […]

Introduction and Objective: Diabetic foot ulcer (DFUs) are a major cause of hospitalizations, yet post-discharge care coordination remains suboptimal. Effective care organization among specialists is crucial for limb salvage. Patient navigators are an effective model for chronic disease management, but their impact on DFU care is understudied. Here, we evaluated the use of certified diabetes […]

Introduction and Objective: Transition from pediatric to adult diabetes care is a complex process for YA with T1D. However, little is known about demographic and clinical characteristics of YA who return to pediatric care after initiating the transfer to adult care. We explored characteristics of YA who did or did not return to pediatric care […]

Introduction and Objective: Young adults with type 1 diabetes (T1D) are vulnerable when transitioning from pediatric to adult care. The Young Adult Diabetes Clinic (YADC) employs a multidisciplinary model to facilitate this transition through a single-session orientation led by a behavioral health specialist. We aim to understand the impact of the YADC, participant characteristics, and […]